The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,740.00
Bid: 1,745.00
Ask: 1,746.00
Change: -34.50 (-1.94%)
Spread: 1.00 (0.057%)
Open: 1,776.50
High: 1,776.50
Low: 1,740.00
Prev. Close: 1,774.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Markets in the red with BoE, Fed in focus

Wed, 20th Nov 2013 11:33

- BoE voted unanimously on policy at last meeting- MPC attempts to play down rate-hike fears- Taper in focus ahead of FOMC minutestechMARK 2,627.20 -0.64%FTSE 100 6,670.70 -0.41%FTSE 250 15,181.39 -0.55%UK markets were trading in the red on Wednesday after the Bank of England expressed concerns with the economic recovery and as investors awaited the minutes of the latest Federal Reserve policy meeting. A number of heavyweight stocks were providing a drag on London's FTSE 100 index by midday after going ex-dividend, meaning that from today investors won't be able to get their hands on the companies' latest payouts.It was revealed this morning that the Bank of England's Monetary Policy Committee (MPC) voted unanimously to maintain the Bank Rate at 0.5% and the stock of asset purchases at £375bn at its latest meeting, as expected. However, the MPC attempted to ease fears over a sooner-than-expected tightening in monetary policy as the minutes of the meeting expressed "uncertainties over the durability of the recovery". The central bank reiterated that rates would be kept low until the unemployment rate reaches the 7% threshold, at which point policymakers would then reassess its stance.Analyst Philip Shaw from Investec said that the minutes didn't provide any firm clues to the timing of a possible rate increase. "Rather they conveyed the degree of uncertainty on the committee on the economic outlook and the recovery in productivity, which will be key factors in the monetary policy debate," he said.Meanwhile, the Federal Open Market Committee (FOMC) will release details of its October meeting later this evening as markets wait to hear about the central bank's decision to maintain its stimulus programme last month.However, comments from Fed Chairman Ben Bernanke last night were in focus this morning after he reiterated that any tapering of asset purchases remains dependent on incoming economic data, as he held back from shedding any light on the timetable for an impending withdrawal.Telecom Plus soars after H1 results, acquisitionsUtilities reseller Telecom Plus was a high riser this morning after agreeing to pay £218m to buy back two gas and electricity supply businesses from Npower which it sold in 2006. The announcement came as the firm delivered a 17% increase in revenues in the first half, as profits rose 10.1%.Ex-div stocks were weighing on the FTSE 100 with Vodafone, Tate & Lyle, Next, Carnival and Sainsbury among the stocks trading without the right to their latest payouts.Drinks group Diageo was under the weather after Chief Executive Ivan Menezes was reported as saying that the "uncertain" macro environment will continue to limit sales growth. Sector peer SABMiller was also out of favour this morning.Airline group easyJet was extending gains made yesterday after the company delivered a 51% increase in annual profits and unveiled an unexpected special dividend to shareholders.GlaxoSmithKline rose after completing the partial sale of Aspen Pharmacare, raising gross proceeds of 7.06bn South African rand ($695m).Engineering and construction firm Kentz was higher after being awarded a $190m contract with Qatar Petroleum for services on 775 wells across the Dukhan Oilfield in Qatar, extending the firms' long-standing relationship which started back in 1997.Fund manager Aberdeen rose after analysts at Bank of America Merrill Lynch upgraded their rating on the stock from 'underperform' to 'neutral'. FTSE 100 - RisersAberdeen Asset Management (ADN) 484.90p +2.04%British Sky Broadcasting Group (BSY) 838.50p +1.64%Travis Perkins (TPK) 1,752.00p +1.57%easyJet (EZJ) 1,362.00p +1.26%Pearson (PSON) 1,342.00p +0.98%Johnson Matthey (JMAT) 3,116.00p +0.84%Aviva (AV.) 429.90p +0.68%Rio Tinto (RIO) 3,277.50p +0.57%William Hill (WMH) 363.10p +0.50%Royal Dutch Shell 'B' (RDSB) 2,200.00p +0.46%FTSE 100 - FallersRexam (REX) 488.50p -2.98%Vodafone Group (VOD) 227.15p -2.11%Amec (AMEC) 1,160.00p -2.03%Hammerson (HMSO) 505.00p -1.94%Persimmon (PSN) 1,163.00p -1.86%Melrose Industries (MRO) 298.20p -1.84%Tate & Lyle (TATE) 806.50p -1.77%Bunzl (BNZL) 1,368.00p -1.72%Sainsbury (J) (SBRY) 404.80p -1.68%Vedanta Resources (VED) 955.00p -1.65%FTSE 250 - RisersTelecom Plus (TEP) 1,745.00p +15.79%International Personal Finance (IPF) 591.50p +2.69%Kentz Corporation Ltd. (KENZ) 555.50p +2.49%Lancashire Holdings Limited (LRE) 811.50p +2.40%BH Global Ltd. USD Shares (BHGU) 11.91 +1.79%Rathbone Brothers (RAT) 1,559.00p +1.56%BH Macro Ltd. EUR Shares (BHME) € 20.00 +1.52%NMC Health (NMC) 375.50p +1.49%BH Macro Ltd. USD Shares (BHMU) 19.69 +1.44%BTG (BTG) 446.30p +1.39%FTSE 250 - FallersTalkTalk Telecom Group (TALK) 266.20p -3.55%Centamin (DI) (CEY) 48.19p -3.43%Spirent Communications (SPT) 102.20p -3.31%Bovis Homes Group (BVS) 744.50p -2.93%African Barrick Gold (ABG) 186.40p -2.76%ITE Group (ITE) 304.10p -2.69%Kenmare Resources (KMR) 20.49p -2.66%Wood Group (John) (WG.) 788.50p -2.41%Ashmore Group (ASHM) 378.70p -2.40%Hiscox Ltd (HSX) 662.00p -2.36%BC
More News
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.